REVANCE THERAPEUTICS INC

CUSIP: 761330AB5 Class: NOTE 1.750% 2/1

MORGAN STANLEY's Holding History (CIK: 0000895421)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 44,000 Value ($000) $42 Avg Close — Range —
Q3 2024
Shares 2,924,000 Value ($000) $2,472 Avg Close — Range —
Q2 2024
Shares 4,855,000 Value ($000) $3,185 Avg Close — Range —
Q1 2024
Shares 1,415,000 Value ($000) $1,029 Avg Close — Range —
Q4 2023
Shares 3,592,000 Value ($000) $2,712 Avg Close — Range —
Q3 2023
Shares 3,047,000 Value ($000) $2,438 Avg Close — Range —
Q2 2023
Shares 3,597,000 Value ($000) $3,777 Avg Close — Range —
Q1 2023
Shares 3,736,000 Value ($000) $4,582 Avg Close — Range —
Q4 2022
Shares 3,871,000 Value ($000) $3,534 Avg Close — Range —
Q3 2022
Shares 3,371,000 Value ($000) $3,645 Avg Close — Range —
Q2 2022
Shares 5,388,000 Value ($000) $4,274 Avg Close — Range —
Q1 2022
Shares 4,208,000 Value ($000) $3,972 Avg Close — Range —
Q4 2021
Shares 4,208,000 Value ($000) $3,692 Avg Close — Range —
Q3 2021
Shares 4,133,000 Value ($000) $4,745 Avg Close — Range —
Q2 2021
Shares 7,152,000 Value ($000) $8,351 Avg Close — Range —
Q1 2021
Shares 8,232,000 Value ($000) $9,224 Avg Close — Range —